Physician

William David Shoemaker, M.D.

According to 2025 Medicare claims, William Shoemaker, M.D. (NPI: 1740642925) practices rheumatology in the Wilmington, NC market, with the plurality of this provider's patient population coming from Brunswick, NC. This provider's primary affiliated billing organization is WILMINGTON HEALTH PLLC (NPI: 1881632339; TIN: 561980160) and primary practice location at 28401-7684.

Shoemaker's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 313 traditional Medicare patients, billed 57,709 HCPCS/CPT codes, and received $407,165 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,447 prescription claims across 280 beneficiaries totaling $988,205 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 125 records totaling $2,468. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,656 to $988,205. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$204K$407K2022 Medicare payment: $14,439 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $154,329 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $407,165 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202259555$14,439
202320920,593$154,329
202431357,709$407,165

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$494K$988K2017 Drug cost: $2,656 (USD; Tot_Drug_Cst)2020 Drug cost: $28,815 (USD; Tot_Drug_Cst)2021 Drug cost: $368,257 (USD; Tot_Drug_Cst)2022 Drug cost: $339,004 (USD; Tot_Drug_Cst)2023 Drug cost: $873,708 (USD; Tot_Drug_Cst)2024 Drug cost: $988,205 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171140$2,656
2018N/RN/RN/R
2019N/RN/RN/R
20201544$28,815
202142237$368,257
202278387$339,004
20232041,019$873,708
20242801,447$988,205

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more151298$87
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's169300$12
36415Insertion of needle into vein for collection of blood sample200419$9
86140Measurement c-reactive protein for detection of infection or inflammation160257$5
85652Red blood cell sedimentation rate, to detect inflammation, automated163264$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept391,204$327,707
Humira(Cf) PenAdalimumab14448$111,130
OtezlaApremilast18538$87,727
Hydroxychloroquine SulfateHydroxychloroquine Sulfate22311,196$7,544
MethotrexateMethotrexate Sodium23711,147$4,512

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.125$2,468Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for William David Shoemaker, M.D.?

Tedicare shows public-source Medicare data for William David Shoemaker, M.D. (NPI 1740642925), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William David Shoemaker, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to William David Shoemaker, M.D.?

William David Shoemaker, M.D. is linked to WILMINGTON HEALTH PLLC (billing NPI 1881632339) in the available physician profile data.

Does William David Shoemaker, M.D. have Open Payments data?

William David Shoemaker, M.D. has 125 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.